(Q34674585)

3 August 2017

Diagnosis of histoplasmosis by antigen detection based upon experience at the histoplasmosis reference laboratory (English)

1 reference

3 August 2017

1 reference

1

L Joseph Wheat

1 reference

3 August 2017

Todd Garringer

2

1 reference

PubMed ID

12052626

3 August 2017

Ed Brizendine

series ordinal

3

1 reference

PubMed ID

12052626

3 August 2017

Patricia Connolly

series ordinal

4

1 reference

3 August 2017

1 May 2002

1 reference

Diagnostic Microbiology and Infectious Disease

3 August 2017

1 reference

3 August 2017

43

1 reference

3 August 2017

1

1 reference

3 August 2017

29-37

1 reference

Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Disseminated histoplasmosis in immunologically suppressed patients. Occurrence in a nonendemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Chronic infection and reactivation in a pulmonary challenge model of histoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Comparison of nikkomycin Z with amphotericin B and itraconazole for treatment of histoplasmosis in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Development of a novel antigen detection test for histoplasmosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Histoplasmosis in normal hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Acute pulmonary histoplasmosis presenting as adult respiratory distress syndrome: effect of therapy on clinical and laboratory features

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Histoplasmosis. Experience during outbreaks in Indianapolis and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Histoplasma capsulatum infections of the central nervous system. A clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Diagnosis of disseminated histoplasmosis by detection of Histoplasma capsulatum antigen in serum and urine specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Significance of Histoplasma antigen in the cerebrospinal fluid of patients with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

A Large Urban Outbreak of Histoplasmosis: Clinical Features

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

Correlation of Histoplasma capsulatum polysaccharide antigen with the severity of infection in murine histoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2802%2900367-X

7 January 2021

10.1016/S0732-8893(02)00367-X

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12052626